Dr. David Baratz

Dr. David Baratz brings 20 years of experience in pulmonary medicine to his patients at the Pulmonary Associates medical practice in Phoenix. For patients’ convenience, the group maintains six Arizona office locations, including four in Phoenix, one in Gilbert, and their newest facility in Glendale. As owner of the clinic, David Baratz, M.D., diagnoses and treats a wide variety of pulmonary diseases and conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD).

In addition to providing exemplary pulmonary care, Dr. David Baratz remains board certified in the subspecialty of pulmonary medicine, a certification that he earned in 1992. He holds recognition as a nationally recognized expert in the field of pulmonary arterial hypertension, with his articles on the subject appearing in medical journals such as Circulation, Chest, and The Journal of Heart and Lung Transplantation. Additionally, Dr. David Baratz has conducted numerous clinical trials related to pulmonary arterial hypertension, and he continues to lead lectures nationwide on its diagnosis and treatment.

Dr. David Baratz and his colleagues at Pulmonary Associates perform a variety of procedures to diagnose pulmonary arterial hypertension, all of which may be completed at their offices or any of three area hospitals. These methods include pulmonary function testing, exercise evaluation, and cardiac catheterization performed in conjunction with other specialists such as hepatologists, cardiologists, and rheumatologists. Once the patient is diagnosed with pulmonary arterial hypertension, David Baratz, M.D., prescribes an individual course of treatment, taking the patient’s other medical conditions and history into account.

Dr. David Baratz played an integral role in the development of intravenous epoprostenol (Flolan) therapy to treat pulmonary arterial hypertension, with Pulmonary Associates involved in many vital research studies for this and other new therapy plans. At Pulmonary Associates, Dr. Baratz uses the latest in medical technology, including medications and state-of-the-art testing equipment, to treat patients with this condition.